Page last updated: 2024-08-18

2-aminopyrimidine and Progeria

2-aminopyrimidine has been researched along with Progeria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauvais, C; Bifulco, M; Blondel, S; Bollot, G; Brinon, B; De Sandre-Giovannoli, A; Egesipe, AL; Ferreira, L; Georges, P; Jaskowiak, AL; Laustriat, D; Le Corf, A; Levy, N; Mejat, A; Navarro, C; Nissan, X; Notarnicola, M; Peschanski, M; Picardi, P; Pitrez, PR; Poydenot, P; Ragot, J; Tournois, J	1

Other Studies

1 other study(ies) available for 2-aminopyrimidine and Progeria

Article	Year
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation. Cell death & disease, 2016, Feb-18, Volume: 7 Topics: Binding Sites; Cell Differentiation; Farnesyltranstransferase; Geranyltranstransferase; Humans; Lamin Type A; Molecular Docking Simulation; Osteogenesis; Pluripotent Stem Cells; Progeria; Protein Prenylation; Protein Structure, Tertiary; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship	2016

Article

Year

Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

Cell death & disease, 2016, Feb-18, Volume: 7

Topics: Binding Sites; Cell Differentiation; Farnesyltranstransferase; Geranyltranstransferase; Humans; Lamin Type A; Molecular Docking Simulation; Osteogenesis; Pluripotent Stem Cells; Progeria; Protein Prenylation; Protein Structure, Tertiary; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship

2016